Dabigatrán: experiencia en la práctica clínica habitual
- 1 October 2015
- journal article
- Published by Elsevier in Revista Clínica Española
- Vol. 215 (7) , 385-390
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European CountriesClinical Therapeutics, 2014
- Myocardial Ischemic Events in ‘Real World’ Patients with Atrial Fibrillation Treated with Dabigatran or WarfarinThe American Journal of Medicine, 2014
- Meta-Analysis of Randomized Controlled Trials on Risk of Myocardial Infarction from the Use of Oral Direct Thrombin InhibitorsThe American Journal of Cardiology, 2013
- New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysisGastroenterology, 2013
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial FibrillationJACC, 2013
- Dabigatran Association With Higher Risk of Acute Coronary EventsArchives of internal medicine (1960), 2012
- Dabigatran EtexilateCirculation, 2011
- Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarctionJournal of Internal Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAnnals of Internal Medicine, 2003